Quest Diagnostics Cost of Goods Sold 2010-2024 | DGX

Quest Diagnostics annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Quest Diagnostics cost of goods sold for the quarter ending September 30, 2024 was $1.677B, a 8.83% increase year-over-year.
  • Quest Diagnostics cost of goods sold for the twelve months ending September 30, 2024 was $6.417B, a 3.13% increase year-over-year.
  • Quest Diagnostics annual cost of goods sold for 2023 was $6.199B, a 3.89% decline from 2022.
  • Quest Diagnostics annual cost of goods sold for 2022 was $6.45B, a 1.96% decline from 2021.
  • Quest Diagnostics annual cost of goods sold for 2021 was $6.579B, a 13.35% increase from 2020.
Quest Diagnostics Annual Cost of Goods Sold
(Millions of US $)
2023 $6,199
2022 $6,450
2021 $6,579
2020 $5,804
2019 $5,037
2018 $4,926
2017 $4,719
2016 $4,616
2015 $4,657
2014 $4,637
2013 $4,326
2012 $4,365
2011 $4,363
2010 $4,276
2009 $4,321
Quest Diagnostics Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $1,677
2024-06-30 $1,593
2024-03-31 $1,595
2023-12-31 $1,552
2023-09-30 $1,541
2023-06-30 $1,546
2023-03-31 $1,560
2022-12-31 $1,575
2022-09-30 $1,618
2022-06-30 $1,611
2022-03-31 $1,646
2021-12-31 $1,718
2021-09-30 $1,670
2021-06-30 $1,565
2021-03-31 $1,626
2020-12-31 $1,733
2020-09-30 $1,580
2020-06-30 $1,221
2020-03-31 $1,270
2019-12-31 $1,264
2019-09-30 $1,264
2019-06-30 $1,265
2019-03-31 $1,244
2018-12-31 $1,235
2018-09-30 $1,222
2018-06-30 $1,243
2018-03-31 $1,226
2017-12-31 $1,194
2017-09-30 $1,190
2017-06-30 $1,170
2017-03-31 $1,165
2016-12-31 $1,160
2016-09-30 $1,157
2016-06-30 $1,155
2016-03-31 $1,144
2015-12-31 $1,150
2015-09-30 $1,162
2015-06-30 $1,182
2015-03-31 $1,163
2014-12-31 $1,184
2014-09-30 $1,178
2014-06-30 $1,174
2014-03-31 $1,101
2013-12-31 $1,051
2013-09-30 $1,089
2013-06-30 $1,094
2013-03-31 $1,092
2012-12-31 $1,073
2012-09-30 $1,081
2012-06-30 $1,102
2012-03-31 $1,109
2011-12-31 $1,045
2011-09-30 $1,117
2011-06-30 $1,104
2011-03-31 $1,097
2010-12-31 $1,039
2010-09-30 $1,091
2010-06-30 $1,079
2010-03-31 $1,066
2009-12-31 $1,070
2009-09-30 $1,098
2009-06-30 $1,100
2009-03-31 $1,053
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.988B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00